CARAFATE Side Effects

6971511-X | Alanine Aminotransferase Increased, Amenorrhoea, Aspartate Aminotransferase Increased, Liver Injury
on Aug 26, 2010 Female patient from UNITED STATES , 22 years of age, was treated with Carafate (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, amenorrhoea, aspartate aminotransferase increased, liver injury. Carafate dosage: . During the same period patient was treated with REBIF (44 Ug, 3 Times/week, Subcutaneous) (View Rebif Review and Rebif Label ), NEXIUM (View Nexium Review and Nexium Label ), DEXILANT (View Dexilant Review and Dexilant Label ), CIPRO (View Cipro Review and Cipro Label ), SINGULAIR (View Singulair Review and Singulair Label ).

6919102-0 | Glycosylated Haemoglobin Increased, Increased Insulin Requirement
Patient was taking Carafate (View Usage). Patient had the following side effects: glycosylated haemoglobin increased, increased insulin requirement on Jul 27, 2010 from UNITED STATES Additional patient health information: Female patient , 62 years of age, was diagnosed with nausea (What is nausea?) and. Carafate dosage: 2 Tablespoons. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), PRILOSEC (OMEPRAZOLE) (View Prilosec (omeprazole) Review and Prilosec (omeprazole) Label ), LIBRAX (CHLORIDAZEPOXIDE CLIDINIUM) (View Librax (chloridazepoxide Clidinium) Review and Librax (chloridazepoxide Clidinium) Label ).

6919096-8 | Blood Glucose Increased
Adverse event was reported on May 15, 2008 by a Male patient taking Carafate (View Usage) (Dosage: 10 Ml, Tid To Qid, Oral) was diagnosed with gastric ulcer and. Location: UNITED STATES , 75 years of age, After Carafate was administered, patient had the following side effects: blood glucose increased.

6919095-6 | Blood Glucose Abnormal, Dizziness, Oesophageal Pain, Vision Blurred
on Mar 04, 2008 Male patient from UNITED STATES , 70 years of age, was diagnosed with gastric ulcer and was treated with Carafate (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose abnormal, dizziness (What is dizziness?), oesophageal pain, vision blurred. Carafate dosage: 10 Ml, Tid, Oral.


6919076-2 | Blood Glucose Increased
on Jan 13, 2006 Female patient from UNITED STATES , 50 years of age, weighting 200.0 lb, was treated with Carafate (View Usage). Patient had the following side effects: blood glucose increased. Carafate dosage: 1g; Qid; Po.

6919075-0 | Blood Glucose Increased
Patient was taking Carafate (View Usage). After Carafate was administered, patient had the following side effects: blood glucose increased on Oct 05, 2007 from UNITED STATES Additional patient health information: Male patient , 54 years of age, . Carafate dosage: .

6919045-2 | Diarrhoea, Hyperglycaemia
Adverse event was reported on Jun 22, 2004 by a Male patient taking Carafate (View Usage) (Dosage: ) . Location: UNITED STATES , 68 years of age, Patient experienced the following unwanted or unexpected effects: diarrhoea, hyperglycaemia.

6895672-6 | Migraine, Product Label Issue
on Jul 30, 2010 Female patient from UNITED STATES , 54 years of age, weighting 215.4 lb, was diagnosed with oesophageal ulcer and was treated with Carafate (View Usage). Patient had the following side effects: migraine (What is migraine?), product label issue. Carafate dosage: 2 Tsp. 2 X Sy Oral.

6895426-0 | Asthenia, Confusional State, Fall, Haemodialysis, Mental Status Changes, Urinary Tract Infection
on Jul 30, 2010 Female patient from UNITED STATES , 77 years of age, weighting 154.3 lb, was diagnosed with prophylaxis, ulcer (What is ulcer?) and was treated with Carafate (View Usage). After Carafate was administered, patient had the following side effects: asthenia, confusional state, fall (What is fall?), haemodialysis, mental status changes, urinary tract infection (What is urinary tract infection?). Carafate dosage: Carafate 1 Gram Qid Po. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), PLAVIX (View Plavix Review and Plavix Label ), PEPCID (View Pepcid Review and Pepcid Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), RANEXA (View Ranexa Review and Ranexa Label ), PHOSLO (View Phoslo Review and Phoslo Label ).

6745174-2 | Anxiety, Chest Pain, Cholelithiasis, Weight Decreased
Patient was taking Carafate (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), chest pain (What is chest pain?), cholelithiasis, weight decreased on May 17, 2010 from UNITED STATES Additional patient health information: Male patient , 37 years of age, weighting 313.9 lb, was diagnosed with bipolar disorder (What is bipolar disorder?) and. Carafate dosage: 1 Mg, Qid. During the same period patient was treated with DICYCLOMINE HCL (10 Mg, Bid,) (View Dicyclomine Hcl Review and Dicyclomine Hcl Label ), GEODON (40 Mg, Qd, Oral) (View Geodon Review and Geodon Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), AMBIEN (View Ambien Review and Ambien Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), NEXUM (ESOMEPRAZOLE MAGNESIUM) (View Nexum (esomeprazole Magnesium) Review and Nexum (esomeprazole Magnesium) Label ), SYNTHROID (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

6724679-4 | Anxiety, Chest Pain, Cholelithiasis, Condition Aggravated, Weight Decreased
Adverse event was reported on May 03, 2010 by a Male patient taking Carafate (View Usage) (Dosage: 1mg, Qid,) was diagnosed with bipolar disorder (What is bipolar disorder?) and. Location: UNITED STATES , 37 years of age, weighting 313.9 lb, Patient had the following side effects: anxiety (What is anxiety?), chest pain (What is chest pain?), cholelithiasis, condition aggravated, weight decreased. During the same period patient was treated with DICYCLOMINE HCL (10 Mg, Bid) (View Dicyclomine Hcl Review and Dicyclomine Hcl Label ), GEODON (40 Mg, Qd, Oral) (View Geodon Review and Geodon Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), AMBIEN (View Ambien Review and Ambien Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), NEXUM (ESOMEPRAZOLE MAGNESIUM) (View Nexum (esomeprazole Magnesium) Review and Nexum (esomeprazole Magnesium) Label ), SYNTHROID (View Synthroid Review and Synthroid Label ). Patient was hospitalized.

6699466-6 | Condition Aggravated, Feeling Abnormal, Memory Impairment
on Apr 15, 2010 Female patient from UNITED STATES , 55 years of age, was diagnosed with gastrooesophageal reflux disease, fluid retention, multiple allergies, diabetic neuropathy, fibromyalgia, arthralgia, muscle spasms, hypertension, depression (What is depression?) and was treated with Carafate (View Usage). After Carafate was administered, patient had the following side effects: condition aggravated, feeling abnormal, memory impairment. Carafate dosage: 1 G Qd, Oral. During the same period patient was treated with LOZOL (1,25 Mg, Qd, Oral) (View Lozol Review and Lozol Label ), ZYRTEC (10 Md, Qd) (View Zyrtec Review and Zyrtec Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), VICODIN (7.5mg/325 Mg,q4th) (View Vicodin Review and Vicodin Label ), ZANAFLEX (2 Mg, Bid) (View Zanaflex Review and Zanaflex Label ), VALSARTAN (160 Mg Qd) (View Valsartan Review and Valsartan Label ), BUPROPION HCL (300 Mg, Qd) (View Bupropion Hcl Review and Bupropion Hcl Label ).

6538614-5 | Choking Sensation, Dysphonia, Emotional Disorder, Fear, Mental Disorder, Oesophageal Disorder, Oesophageal Spasm, Oropharyngeal Pain
on Jan 13, 2010 Female patient from UNITED STATES , 39 years of age, weighting 147.0 lb, was diagnosed with pharyngeal disorder and was treated with Carafate (View Usage). Patient experienced the following unwanted or unexpected effects: choking sensation, dysphonia, emotional disorder, fear, mental disorder, oesophageal disorder, oesophageal spasm, oropharyngeal pain. Carafate dosage: 2 Teaspoons Before Meals/bed Po. Patient was hospitalized.

6382377-3 | Ageusia, Tongue Coated
Patient was taking Carafate (View Usage). Patient had the following side effects: ageusia, tongue coated on Sep 28, 2009 from UNITED STATES Additional patient health information: Female patient , 94 years of age, weighting 135.0 lb, was diagnosed with ulcer (What is ulcer?) and. Carafate dosage: 2 Tsp. 4 Times A Day.

6298059-2 | Acne, Facial Pain, Swelling Face, Urticaria
Adverse event was reported on Aug 04, 2009 by a Female patient taking Carafate (View Usage) (Dosage: 2 Teaspoons, 4 X Per Day, Po) was diagnosed with ulcer (What is ulcer?) and. Location: UNITED STATES , weighting 200.0 lb, After Carafate was administered, patient had the following side effects: acne (What is acne?), facial pain, swelling face, urticaria.

6261079-8 | Deafness Transitory, Hyperacusis, Loss Of Consciousness, Swelling Face
on Jul 06, 2009 Female patient from UNITED STATES , 44 years of age, weighting 245.0 lb, was diagnosed with dyspepsia, epilepsy (What is epilepsy?), blood testosterone, affective disorder, depression (What is depression?), hysterectomy (What is hysterectomy?), migraine (What is migraine?) and was treated with Carafate (View Usage). Patient experienced the following unwanted or unexpected effects: deafness transitory, hyperacusis, loss of consciousness, swelling face. Carafate dosage: 1g Qid; Oral. During the same period patient was treated with PRIMIDONE (1 Tablet; Tid Or Qid) (View Primidone Review and Primidone Label ), METFORMIN HCL (500 Mg, Bid; Oral) (View Metformin Hcl Review and Metformin Hcl Label ), LITHIUM CARBONATE (300mg, Bid; Oral) (View Lithium Carbonate Review and Lithium Carbonate Label ), WELLBUTRIN XL (150mg, Daily; Oral) (View Wellbutrin Xl Review and Wellbutrin Xl Label ), ESTRADIOL (2mg, Bid; Oral) (View Estradiol Review and Estradiol Label ), RELPAX (20mg, Prn; Oral) (View Relpax Review and Relpax Label ), PREVACID (30mg, Bid; Oral) (View Prevacid Review and Prevacid Label ).

6249557-9 | Altered State Of Consciousness, Deafness Transitory, Hyperacusis, Swelling Face
on Jun 25, 2009 Female patient from UNITED STATES , 44 years of age, weighting 245.0 lb, was diagnosed with dyspepsia, epilepsy (What is epilepsy?), blood testosterone, affective disorder, depression (What is depression?), hysterectomy (What is hysterectomy?), migraine (What is migraine?), seasonal affective disorder (What is seasonal affective disorder?) and was treated with Carafate (View Usage). Patient had the following side effects: altered state of consciousness, deafness transitory, hyperacusis, swelling face. Carafate dosage: 1g Qid; Oral. During the same period patient was treated with PRIMIDONE (1 Tablet; Tid Of Qid; From Age 7 Months To 16.5 Years) (View Primidone Review and Primidone Label ), METFORMIN HCL (500 Mg, Bid, Oral) (View Metformin Hcl Review and Metformin Hcl Label ), LITHIUM CARBONATE (300mg, Bid; Oral) (View Lithium Carbonate Review and Lithium Carbonate Label ), WELLBUTRIN XL (150mg, Daily; Oral) (View Wellbutrin Xl Review and Wellbutrin Xl Label ), ESTRADIOL (2mg, Bid; Oral) (View Estradiol Review and Estradiol Label ), RELPAX (20mg, Prn; Oral) (View Relpax Review and Relpax Label ), PREVACID (30mg, Bid; Oral) (View Prevacid Review and Prevacid Label ), BUPROPION (75mg, Daily; Oral) (View Bupropion Review and Bupropion Label ).

6210024-X | Asthenia, Atrial Fibrillation, Cerebral Ischaemia, Pericardial Effusion
Patient was taking Carafate (View Usage). After Carafate was administered, patient had the following side effects: asthenia, atrial fibrillation (What is atrial fibrillation?), cerebral ischaemia, pericardial effusion on May 29, 2009 from UNITED STATES Additional patient health information: Male patient , 63 years of age, was diagnosed with thrombosis prophylaxis and. Carafate dosage: 1g, Q8h, Po. During the same period patient was treated with AMOXICILLIN (500mg; Bid, Po) (View Amoxicillin Review and Amoxicillin Label ), FLUCONAZOLE (100mg; Qam Po) (View Fluconazole Review and Fluconazole Label ), PREVACID (30mg; Bid, Po) (View Prevacid Review and Prevacid Label ), THROMBIN RECEPTOR ANTAGONIST (NOT SPECIFIED) (Oral) (View Thrombin-receptor Antagonist (not Specified) Review and Thrombin-receptor Antagonist (not Specified) Label ), THROMBIN RECEPTOR ANTAGONIST (NOT SPECIFIED) (Oral) (View Thrombin-receptor Antagonist (not Specified) Review and Thrombin-receptor Antagonist (not Specified) Label ), CLARITHROMYCIN (500mg; Bid, Po) (View Clarithromycin Review and Clarithromycin Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

6163764-5 | Hyperglycaemia, Impaired Gastric Emptying
Adverse event was reported on Apr 20, 2009 by a Female patient taking Carafate (View Usage) (Dosage: 1gm Qid) . Location: UNITED STATES , 18 years of age, Patient experienced the following unwanted or unexpected effects: hyperglycaemia, impaired gastric emptying. During the same period patient was treated with NEURONTIN (500 Mg, Tid, Oral) (View Neurontin Review and Neurontin Label ), METOCLOPRAMIDE HCL (3.5mg, Q8h, Oral) (View Metoclopramide Hcl Review and Metoclopramide Hcl Label ). Patient was hospitalized.

6158591-9 | Amyotrophic Lateral Sclerosis, Aphasia
on Apr 02, 2009 Female patient from UNITED STATES , 76 years of age, was treated with Carafate (View Usage). Patient had the following side effects: amyotrophic lateral sclerosis (What is amyotrophic lateral sclerosis?), aphasia (What is aphasia?). Carafate dosage: 10 Ml Tid Oral. During the same period patient was treated with NASONEX (MOMETASONE FUROATE MONOHYDRATE) (View Nasonex (mometasone Furoate Monohydrate) Review and Nasonex (mometasone Furoate Monohydrate) Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ).

6109542-4 |
on Feb 19, 2009 Female patient from UNITED STATES , 47 years of age, was treated with Carafate (View Usage). . Carafate dosage: .

6106896-X | Hyperglycaemia, Impaired Gastric Emptying
Patient was taking Carafate (View Usage). Patient experienced the following unwanted or unexpected effects: hyperglycaemia, impaired gastric emptying on Feb 20, 2009 from UNITED STATES Additional patient health information: Female patient , 19 years of age, . Carafate dosage: 1gm, Qid,. During the same period patient was treated with NEURONTIN (500mg, Tid, Oral) (View Neurontin Review and Neurontin Label ), METOCLOPRAMIDE HCL (5mg, Q8h, Oral) (View Metoclopramide Hcl Review and Metoclopramide Hcl Label ). Patient was hospitalized.

6023613-2 | Burning Sensation, Cardiac Fibrillation, Dizziness, Headache, Migraine With Aura, Nausea, Somnolence, Urticaria, Vision Blurred
Adverse event was reported on Dec 26, 2008 by a Female patient taking Carafate (View Usage) (Dosage: 2 Teaspoonful - 1 Gram 2x/day Po) was diagnosed with ulcer (What is ulcer?) and. Location: UNITED STATES , 82 years of age, weighting 110.0 lb, Patient had the following side effects: burning sensation, cardiac fibrillation, dizziness (What is dizziness?), headache (What is headache?), migraine with aura, nausea (What is nausea?), somnolence, urticaria, vision blurred.

5956206-3 | Abdominal Pain Upper, Chest Pain, Dysgeusia, Malaise, Nausea, Product Quality Issue
on Nov 04, 2008 Female patient from UNITED STATES , 77 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with Carafate (View Usage). After Carafate was administered, patient had the following side effects: abdominal pain upper, chest pain (What is chest pain?), dysgeusia, malaise, nausea (What is nausea?), product quality issue. Carafate dosage: 2 Tsp Tid Oral. During the same period patient was treated with CORDARONE (View Cordarone Review and Cordarone Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), ECOPRIN (ACETYLSALICYLIC ACID) (View Ecoprin (acetylsalicylic Acid) Review and Ecoprin (acetylsalicylic Acid) Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ESTRATES (ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE) (View Estrates (esterified Estrogens And Methyltestosterone) Review and Estrates (esterified Estrogens And Methyltestosterone) Label ), SYMBYAX (View Symbyax Review and Symbyax Label ), ZANTAC (View Zantac Review and Zantac Label ), MACRODANTIN (View Macrodantin Review and Macrodantin Label ). Patient was hospitalized.

5475653-X | Anaemia, Dementia
on Sep 17, 2007 Female patient from UNITED STATES , 83 years of age, was treated with Carafate (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, dementia (What is dementia?). Carafate dosage: Oral. During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), CORTISONE ACETATE TAB (View Cortisone Acetate Tab Review and Cortisone Acetate Tab Label ).

5350804-6 | Migraine
Patient was taking Carafate (View Usage). Patient had the following side effects: migraine (What is migraine?) on Jun 06, 2007 from UNITED STATES Additional patient health information: Female patient , 48 years of age, weighting 124.0 lb, . Carafate dosage: 2 Teaspoons Before Meals + Bed Po.

5226352-0 | Blood Aluminium Increased
Adverse event was reported on Jan 11, 2007 by a Male patient taking Carafate (View Usage) (Dosage: ) . Location: UNITED STATES , 47 years of age, After Carafate was administered, patient had the following side effects: blood aluminium increased. Patient was hospitalized.

5104789-8 | Blood Pressure Increased, Dysphagia, Dyspnoea, Headache, Heart Rate Increased, Neck Pain, Panic Disorder, Panic Reaction, Pharyngeal Hypoaesthesia
on Sep 11, 2006 Female patient from UNITED STATES , 55 years of age, weighting 155.0 lb, was diagnosed with ulcer (What is ulcer?) and was treated with Carafate (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, dysphagia, dyspnoea, headache (What is headache?), heart rate increased, neck pain, panic disorder (What is panic disorder?), panic reaction, pharyngeal hypoaesthesia. Carafate dosage: 1g 4 Per Day Po.

5010600-6 | Dizziness, Hunger, Tremor
on May 24, 2006 Female patient from UNITED STATES , 56 years of age, weighting 106.0 lb, was diagnosed with ulcer (What is ulcer?) and was treated with Carafate (View Usage). Patient had the following side effects: dizziness (What is dizziness?), hunger, tremor. Carafate dosage: One Tab Twice Daily Twice Daily Po.

4947921-9 | Gastrointestinal Pain, Nausea, Throat Irritation
Patient was taking Carafate (View Usage). After Carafate was administered, patient had the following side effects: gastrointestinal pain, nausea (What is nausea?), throat irritation on Mar 17, 2006 from UNITED STATES Additional patient health information: Female patient , 82 years of age, was diagnosed with burning sensation, gastrooesophageal reflux disease and. Carafate dosage: 10ml Four Times Daily. During the same period patient was treated with ZYRTEC (View Zyrtec Review and Zyrtec Label ), LASIX (View Lasix Review and Lasix Label ), KLONOPIN (View Klonopin Review and Klonopin Label ).

4816864-3 | Incorrect Dose Administered
Adverse event was reported on Oct 28, 2005 by a Female patient taking Carafate (View Usage) (Dosage: 2 Teaspoon Fulls 4 X Day Oral) was diagnosed with oesophagitis and. Location: UNITED STATES , weighting 145.0 lb, Patient experienced the following unwanted or unexpected effects: incorrect dose administered.

4815363-2 | Abdominal Discomfort, Stomach Discomfort
on Oct 20, 2005 Female patient from UNITED STATES , 74 years of age, weighting 120.0 lb, was treated with Carafate (View Usage). Patient had the following side effects: abdominal discomfort, stomach discomfort. Carafate dosage: . During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), TIZANIDINE HCL (View Tizanidine Hcl Review and Tizanidine Hcl Label ), ZOLPIDEM (AMBIEN) TABLET (View Zolpidem (ambien) Tablet Review and Zolpidem (ambien) Tablet Label ), PROPOXYPHENE ACETAMINOPHEN (DARVOCET N) TABLET (View Propoxyphene-acetaminophen (darvocet-n) Tablet Review and Propoxyphene-acetaminophen (darvocet-n) Tablet Label ), CLOTRIMAZOLE (View Clotrimazole Review and Clotrimazole Label ).

4674435-6 | Bone Disorder, Oral Candidiasis, Osteonecrosis, Tooth Extraction
on Jan 13, 2005 Female patient from , 58 years of age, weighting 200.6 lb, was diagnosed with gastrooesophageal reflux disease, breast cancer metastatic, pain (What is pain?), constipation (What is constipation?), nausea (What is nausea?) and was treated with Carafate (View Usage). After Carafate was administered, patient had the following side effects: bone disorder, oral candidiasis, osteonecrosis (What is osteonecrosis?), tooth extraction. Carafate dosage: 1 G, Qid. During the same period patient was treated with FEMARA (2.5 Mg, Qd) (View Femara Review and Femara Label ), MS CONTIN (15-30 Mg, Q12h) (View Ms Contin Review and Ms Contin Label ), MOTRIN (600 Mg, Prn) (View Motrin Review and Motrin Label ), PREVACID (30 Mg, Prn) (View Prevacid Review and Prevacid Label ), SENOKOT /USA/ (1-4 Tablets, Bid) (View Senokot /usa/ Review and Senokot /usa/ Label ), MIRALAX (17 G, Prn) (View Miralax Review and Miralax Label ), ZOFRAN (32 Mg, Unk) (View Zofran Review and Zofran Label ).

4673210-6 | Bone Disorder, Oral Candidiasis, Osteonecrosis, Tooth Extraction
Patient was taking Carafate (View Usage). Patient experienced the following unwanted or unexpected effects: bone disorder, oral candidiasis, osteonecrosis (What is osteonecrosis?), tooth extraction on Jan 13, 2005 from Additional patient health information: Female patient , 58 years of age, weighting 200.6 lb, was diagnosed with gastrooesophageal reflux disease, breast cancer metastatic, pain (What is pain?), constipation (What is constipation?), nausea (What is nausea?) and. Carafate dosage: 1 G, Qid. During the same period patient was treated with FEMARA (2.5 Mg, Qd) (View Femara Review and Femara Label ), MS CONTIN (15-30 Mg, Q12h) (View Ms Contin Review and Ms Contin Label ), MOTRIN (600 Mg, Prn) (View Motrin Review and Motrin Label ), PREVACID (30 Mg, Prn) (View Prevacid Review and Prevacid Label ), SENOKOT /USA/ (1-4 Tablets, Bid) (View Senokot /usa/ Review and Senokot /usa/ Label ), MIRALAX (17 G, Prn) (View Miralax Review and Miralax Label ), ZOFRAN (32 Mg, Unk) (View Zofran Review and Zofran Label ).

4604065-3 | Rash
Adverse event was reported on Mar 09, 2005 by a Male patient taking Carafate (View Usage) (Dosage: 1 Gm Q D) was diagnosed with gastric ulcer and. Location: , 50 years of age, Patient had the following side effects: rash (What is rash?).

4595405-2 | Rash
on Feb 28, 2005 Male patient from , 50 years of age, was diagnosed with gastric ulcer and was treated with Carafate (View Usage). After Carafate was administered, patient had the following side effects: rash (What is rash?). Carafate dosage: 1 Gm Qd.

4591234-4 | Rash
on Feb 24, 2005 Male patient from , 50 years of age, was diagnosed with gastric ulcer and was treated with Carafate (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?). Carafate dosage: 1 Gm Qd.

4590336-6 | Rash
Patient was taking Carafate (View Usage). Patient had the following side effects: rash (What is rash?) on Feb 18, 2005 from Additional patient health information: Male patient , 50 years of age, was diagnosed with gastric ulcer and. Carafate dosage: 1 Gm Q D.